Home > Press > NanoInk's NLP 2000 System Now Supports Three New Nanoscale Biology Applications
Abstract:
NanoInk, Inc., a global leader in nanotechnology, is pleased to announce that its NanoFabrication Systems Division instruments have now been proven to support three new applications of importance to biological research. Leveraging patented Dip Pen Nanolithography® (DPN®) technology, NanoInk has demonstrated the successful use of its NLP 2000 System for functionalizing biosensors, patterning functional hydrogels, and printing multiplexed protein arrays.
Launched in 2009 as a tool for bioscience research, the NLP 2000 System is a simple, user-friendly desktop nanolithography platform. It can deposit sub-micron sized features of a wide variety of materials on virtually any planar surface. The NLP 2000 System employs high resolution nanopositioning stages, greatly simplifying the deposition process. With the launch of three new Application Notes that further validates the utility of the NLP 2000 System in biological applications, NanoInk promises to be a valuable partner to the life science community.
Tom Warwick, NanoInk's general manager of sales and marketing, explained that the first of these Application Notes demonstrates successful use of the NLP 2000 System for the functionalization of cantilever-based biosensors. Micro- and nanocantilevers are the most simplified microelectromechanical (MEMS) based devices available for analyte sensing applications.
Nanocantilever biosensors are easily multiplexed and can achieve attogram level sensitivity, so they are particularly well-suited to disease screening, point mutation analysis, blood glucose monitoring, and chemical and biological warfare agent detection. NanoInk has developed a simple and reliable methodology for functionalizing micro- and nanocantilevers using an NLP 2000 System protein deposition approach.
A second new bioscience NLP 2000 System Application Note supports the printing of functional hydrogels. Hydrogels are three-dimensional cross-linked polymer networks that demonstrate physical characteristics very similar to those of natural tissue. As a result, functional hydrogels fabricated at sub-cellular scales have utility in proteomic analyses, drug screening, biological sensor development, and cell culture applications. NanoInk has validated the feasibility of generating consistent and reproducible nanoscale functional PEG hydrogel patterns with the NLP 2000 System.
"With our third new Application Note, we clearly demonstrate that the NLP 2000 System, which is capable of printing multiple substances with nanometer precision at defined locations, is ideal for creating multiplexed protein nanoarrays. Compared to conventional protein microarrays, nanoscale arrays have the benefit of reduced sample and reagent quantities (which lowers assay cost), higher detection sensitivity, improved ability to interrogate sub-cellular features, and better compatibility with lab-on-a-chip technologies," added Warwick.
NanoInk is dedicated to developing and supporting a wide range of biological applications for the NLP 2000 System. These three new Application Notes are just the first step toward proving this commitment.
Please visit www.nanoink.net or call (847) 679-8807 for more information on the NanoFabrication Systems Division, the NLP 2000 System, and related Application Notes.
####
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.
NanoInk, the NanoInk logo, Dip Pen Nanolithography and DPN are trademarks or registered trademarks of NanoInk, Inc.
For more information, please click here
Contacts:
Joshua Taustein
Associate
Dresner Corporate Services
Direct: (312) 780-7219
Mobile: (847) 308-5168
Copyright © NanoInk
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
MEMS
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Sensors
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||